Nufarm Limited FY25 Result

Open PDF
Stock Nufarm Ltd (NUF.ASX)
Release Time 19 Nov 2025, 8:18 a.m.
Price Sensitive Yes
 Nufarm Limited FY25 Result
Key Points
  • Statutory net loss after tax of $165.3 million includes $142.4 million of predominantly non-cash material items
  • Underlying EBITDA (uEBITDA) $302.5 million, -3% on pcp
  • $538 million seasonal unwind in net debt from 1H25, leverage 2.7
Full Summary

Nufarm Limited has announced its results for the year ended 30 September 2025, with statutory and underlying earnings and key balance sheet metrics in line with the August 2025 update. The company reported a statutory net loss after tax of $165.3 million, which includes $142.4 million of predominantly non-cash material items resulting from a review of Seed Technologies and a performance improvement plan. Underlying EBITDA (uEBITDA) was $302.5 million, down 3% on the prior corresponding period (pcp), but up 10% excluding the impact of emerging Omega-3 and Bioenergy platforms. The company's crop protection business performed very well, with uEBITDA up 18% on pcp and growth across all regions, including a record performance in Asia and a material turnaround in Europe. Seed Technologies reported uEBITDA of $13.9 million, primarily impacted by losses in Omega-3 due to a decline in fish oil prices. Nufarm has reprioritised its Seed Technologies strategy, with a focus on reducing cash costs and capital requirements, growing hybrid seeds, expanding Bioenergy, and managing Omega-3 to a cash flow neutral outcome. The company made good progress on cost and working capital, delivering a $538 million seasonal unwind in net debt from the first half, with leverage at 2.7.

Guidance

In FY26, Nufarm expects strong growth in uEBITDA, with continuing growth in Crop Protection and a $30m improvement in uEBITDA from the company's emerging Omega-3 and Bioenergy platforms. Net debt is expected to be below the prior corresponding period, with leverage approximately 2.0 by the end of FY26. Capital expenditure is targeted to be below $200m.

Outlook

Nufarm is well-positioned for uEBITDA growth and positive cash generation in FY26, supported by momentum in Crop Protection, clear direction and opportunity in Seed Technologies, and the company's ability to deleverage through internal discipline and efficiency.